Course of GH treatment | HT (cm) | HT SDS (SDS) | Body weight (kg) | Bone age (y) | Drug dose (IU/kg) | IGF-1 (ng/ml) | Side-effect |
---|---|---|---|---|---|---|---|
prior treatment | 83.5 | −5.80 | 10.0 | 1.5 | - | 52.7 | - |
1 month of therapy | 85.3 | −5.47 | 10.0 | - | 0.11 | 75.8 | N |
3 month of therapy | 87.0 | −5.17 | 10.5 | - | 0.11 | - | N |
6 month of therapy | 88.3 | −5.09 | 11.0 | 2.0 | 0.10 | 99.1 | N |
7 month of therapy | 89.5 | −5.13 | 11.5 | - | 0.10 | - | N |
8 month of therapy | 89.9 | −5.24 | 10.5 | - | 0.11 | - | N |
11 month of therapy | 92.2 | −4.83 | 11.5 | - | 0.12 | - | N |
13 month of therapy | 93.3 | −4.76 | 11.0 | 2.0 | 0.12 | 128.0 | N |
15 months of therapy | 94.8 | −4.70 | 11.5 | - | 0.12 | - | N |
9 months out of therapy | 98.1 | −4.80 | 12.0 | - | 0.12 | - | N |